Inside the research

Ashland Inc.

ASH Research profile · latest available data

Price overview

$69.06

▼ -0.04 (-0.1%)

52w hi$76.01
52w lo$46.20
Vol549.40K
As of25 Sep 2026

The Verdict

Hold

Our score +0.31

Short+0.53
Medium+0.27
Long-0.06

computed 2026-09-27

Key fundamentals

Ashland Inc.

Basic Materials · Specialty Chemicals

Market cap$3.16B
Enterprise value$4.20B
Trailing P/E44.27x
Forward P/E16.02x
EV / EBITDA11.53x
P / S (ttm)1.72x
Profit margin2.8%
Return on equity4.0%
Revenue growth+7.3%
Debt / equity78.93

Layer Breakdown

LayerRawContribution
Fundamental+0.16
Sector-0.02
Technical+0.34
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.

United States · www.ashland.com

Risk Metrics

Beta vs SPX1.05
Corr SPX0.45
Annual vol37.7%
Annual ret-4.6%
Sharpe-0.12
Max DD-47.0%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$64.18
High / Low$75.00 / $50.00
Median$65.00
Analysts11
Strong Buy1
Buy8
Hold3
Sell0
Strong Sell0

Recent rating actions

2026-05-06Seaport Global→ Buy
2026-04-30Wells Fargo→ Equal-Weight
2026-04-30JP Morgan→ Overweight
2026-03-23Argus Research→ Buy
2026-02-18Evercore ISI Group→ In-Line
2026-02-04JP Morgan→ Overweight

Material Events

DateEvent8-K
2026-07-31Material Agreement, Material Obligation…read
2026-07-28Material Agreement, Officer / Director Change…read
2026-07-28Earnings Release, Reg FD Disclosure…read
2026-05-29Material Agreement, Material Obligation…read
2026-05-18Officer / Director Change, Exhibitsread
2026-04-28Earnings Release, Reg FD Disclosure…read
2026-02-02Earnings Release, Reg FD Disclosure…read
2026-01-27Officer / Director Change, Exhibitsread
2026-01-22Shareholder Voteread
2025-11-04Earnings Release, Reg FD Disclosure…read
2025-09-18Officer / Director Changeread
2025-07-29Earnings Release, Reg FD Disclosure…read

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders7
Top-5 share99.8%
HHI4,095 (concentrated)

Top Holders

HolderValueShares
State Street Corp$124.64M1.89M
AQR Capital Management$116.77M1.82M
Capital Research / Capital World$15.37M233.25K
Citadel Advisors$7.02M106.60K
Millennium Management$3.89M59.04K
Fidelity / FMR LLC$564.69K8.57K
T. Rowe Price Group$3.94K59.81K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-08-124view
2026-08-108-K/Aview
2026-08-053view
2026-08-053view
2026-08-054view
2026-08-054view
2026-07-318-Kview
2026-07-304view
2026-07-294view
2026-07-2910-Qview
2026-07-288-Kview
2026-07-288-Kview
2026-07-014view
2026-07-014view
2026-06-1711-Kview

The Long Run

FY 2016–2025 · 9 years

LineLatestCAGRTrend
Revenue$1.82B-7.0%
Gross profit$549.00M-5.8%
Operating income-$775.00M+9.0%
Net income$505.00M+27.8%

Indices

S&P MidCap 400

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$69.10$69.67$68.60$69.06549.40K
Sep 24$69.09$70.17$68.12$69.10747.10K
Sep 23$69.25$70.05$68.52$69.01704.40K
Sep 22$70.15$71.10$69.06$69.66885.40K
Sep 21$69.98$69.99$68.62$69.06571.20K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →